These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34856977)

  • 1. EasyCatch, a convenient, sensitive and specific CRISPR detection system for cancer gene mutations.
    Liu Y; Chen Y; Dang L; Liu Y; Huang S; Wu S; Ma P; Jiang H; Li Y; Pan Y; Wei Y; Ma X; Liu M; Ji Q; Chi T; Huang X; Wang X; Zhou F
    Mol Cancer; 2021 Dec; 20(1):157. PubMed ID: 34856977
    [No Abstract]   [Full Text] [Related]  

  • 2. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas Advancement in Molecular Diagnostics and Signal Readout Approaches.
    Ahmed MZ; Badani P; Reddy R; Mishra G
    J Mol Diagn; 2021 Nov; 23(11):1433-1442. PubMed ID: 34454111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery of CRISPR/Cas systems for cancer gene therapy and immunotherapy.
    Song X; Liu C; Wang N; Huang H; He S; Gong C; Wei Y
    Adv Drug Deliv Rev; 2021 Jan; 168():158-180. PubMed ID: 32360576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR and transposon in vivo screens for cancer drivers and therapeutic targets.
    Noorani I; Bradley A; de la Rosa J
    Genome Biol; 2020 Aug; 21(1):204. PubMed ID: 32811551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
    Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. enAsCas12a Enables CRISPR-Directed Evolution to Screen for Functional Drug Resistance Mutations in Sequences Inaccessible to SpCas9.
    Neggers JE; Jacquemyn M; Dierckx T; Kleinstiver BP; Thibaut HJ; Daelemans D
    Mol Ther; 2021 Jan; 29(1):208-224. PubMed ID: 33002419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survey of clustered regularly interspaced short palindromic repeats and their associated Cas proteins (CRISPR/Cas) systems in multiple sequenced strains of Klebsiella pneumoniae.
    Ostria-Hernández ML; Sánchez-Vallejo CJ; Ibarra JA; Castro-Escarpulli G
    BMC Res Notes; 2015 Aug; 8():332. PubMed ID: 26238567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Research advances on the development and application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein system].
    Tan JJ; Peng YZ; Huang GT
    Zhonghua Shao Shang Za Zhi; 2021 Jul; 37(7):681-687. PubMed ID: 34304411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)/CRISPR-Associated Endonuclease Cas9-Mediated Homology-Independent Integration for Generating Quality Control Materials for Clinical Molecular Genetic Testing.
    Lin G; Zhang K; Peng R; Han Y; Xie J; Li J
    J Mol Diagn; 2018 May; 20(3):373-380. PubMed ID: 29680088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
    Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
    J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR Cas System: An efficient tool for cancer modelling.
    Akhtar M; Jamal T; Khan M; Khan SR; Haider S; Jalil F
    J Pak Med Assoc; 2021 Feb; 71(2(B)):718-724. PubMed ID: 33941966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR/Cas9 for cancer treatment: technology, clinical applications and challenges.
    Cheng X; Fan S; Wen C; Du X
    Brief Funct Genomics; 2020 May; 19(3):209-214. PubMed ID: 32052006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel CRISPR/Cas12a-based genetic diagnostic approach for SLC26A4 mutation-related hereditary hearing loss.
    Jin X; Zhang L; Wang X; An L; Huang S; Dai P; Gao H; Ma X
    Eur J Med Genet; 2022 Feb; 65(2):104406. PubMed ID: 34968750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A CRISPR Way to Identify Cancer Targets.
    Hahn WC
    N Engl J Med; 2019 Jun; 380(25):2475-2477. PubMed ID: 31216404
    [No Abstract]   [Full Text] [Related]  

  • 15. Unleashing CRISPR on Cancer.
    N Engl J Med; 2023 Jun; 388(25):e78. PubMed ID: 37342929
    [No Abstract]   [Full Text] [Related]  

  • 16. Advances in Clustered, Regularly Interspaced Short Palindromic Repeats (CRISPR)-Based Diagnostic Assays Assisted by Micro/Nanotechnologies.
    Yue H; Huang M; Tian T; Xiong E; Zhou X
    ACS Nano; 2021 May; 15(5):7848-7859. PubMed ID: 33961413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic screens: CRISPR-based mapping of genetic interactions.
    Cloney R
    Nat Rev Genet; 2017 May; 18(5):272-273. PubMed ID: 28366937
    [No Abstract]   [Full Text] [Related]  

  • 18. Clustered Regularly Interspaced Short Palindromic Repeats System of Genome Engineering in Embryos to Repair Genes.
    Niazvand F; Fathinezhad Z; Alfuraiji N; Etajuri EA; Amini-Chermahini F; Chehelgerdi M; Ranjbar R
    J Biomed Nanotechnol; 2021 Mar; 17(3):331-356. PubMed ID: 33875070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR-Cas9 for cancer therapy: Opportunities and challenges.
    Chen M; Mao A; Xu M; Weng Q; Mao J; Ji J
    Cancer Lett; 2019 Apr; 447():48-55. PubMed ID: 30684591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applications of the CRISPR-Cas9 system in cancer biology.
    Sánchez-Rivera FJ; Jacks T
    Nat Rev Cancer; 2015 Jul; 15(7):387-95. PubMed ID: 26040603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.